Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.
Also developing:
Can Europe Finance and Keep Its Biotech Winners?
The United States saw a surge of life‑sciences IPOs in early 2026, raising over $1 billion, while Europe continues to lose its biotech firms to foreign markets. Over the past six years, 66 of 67 EU biotech companies that went public listed outside the EU, underscoring a financing and market‑infrastructure gap. The European Life Sciences Coalition (ELSC), representing more than €24 billion (≈$26 billion) in assets, aims to mobilize private and public capital and push policy reforms. Its proposals include a fund‑of‑funds, minimum VC allocations, and a dedicated European biotech exchange to retain talent.
AI Identifies Early Risk Patterns for Skin Cancer
Swedish researchers used nationwide registry data from over 6 million adults to train AI models that predict melanoma risk. The most advanced model reached 73% accuracy, far above the 64% baseline of age‑sex only methods, and identified sub‑populations with a 33%...
Digital Health Systems Keep Failing. The Fix Isn’t More Tech, It’s Designing with and for People
Governments are pouring billions into digital health and civil registration systems, yet many remain underused because they were built without the people who operate them in mind. The Bloomberg Philanthropies Data for Health Global Grants Program found that human‑centered design...
STAT+: Flawed Study on the Antidepressant Paxil Came with a Cautionary Note — if You Knew How to Find It
The Journal of the American Academy of Child & Adolescent Psychiatry issued an expression of concern in late 2025 about a 2001 study that linked the antidepressant Paxil to outcomes in adolescents. The notice followed a formal request to retract...
Partner Therapeutics Reports the US FDA sBLA Submission of Bizengri for NRG1 Fusion Positive Cholangiocarcinoma
Partner Therapeutics has filed a supplemental Biologics License Application (sBLA) with the U.S. FDA for Bizengri (zenocutuzumab‑zbco), a monoclonal antibody designed for adults with advanced unresectable or metastatic cholangiocarcinoma that carry an NRG1 gene fusion. The filing is supported by...
Robotic Phlebotomy Achieves 94% Success, Low Complications
I've been following Vitestro for years. They have been developing robotic devices to collect patients' blood samples. They have big news now as the results of a multicenter ADOPT clinical trial have been published in Clinical Chemistry. That is the...
Doing This Throughout Life May Cut Alzheimer’s Risk by 38%
Researchers tracking 1,939 older adults over eight years found that individuals with the highest lifelong cognitive enrichment experienced a 38% lower risk of Alzheimer’s disease and a 36% lower risk of mild cognitive impairment. The top 10% of participants delayed...
24/7 GP Appointment Booking Is Now Live in the NHS App for More than One Million Patients
Rapid Health’s AI‑powered Smart Triage is now embedded in the NHS App, giving more than one million English patients 24‑hour, seven‑day access to GP appointments. The integration presents each user with an average of 61 available slots, with most selections...
Preparing Trust for Hospital Telemedicine Robots Amid Physician Shortages
Imagine being a physician sitting in front of a laptop webcam while roaming around in a hospital as a telemedicine robot. What a cultural shock it would be! But now North Carolina hospitals are deploying the OhmniCare Telehealth Robot to facilitate...
Boy Who Received Liver, Kidney Transplants From Parents Returns to School
A 12‑year‑old Taiwanese boy received a partial liver transplant from his mother in January 2025 and a living‑donor kidney transplant from his father in January 2026, making him National Taiwan University Hospital's first pediatric case of dual organ transplants within...
Lab Success Doesn't Guarantee Real Cancer Drug Efficacy
Just a reminder. Killing cancer cells in a lab is very easy. Almost anything will kill cells. Even water (because of osmotic damage). Inside our bodies killing cancer cells is extremely hard for many reasons so things that kill...
The Best Non-Surgical Cosmetic Practitioners in 2026
Spear’s 2026 Non‑Surgical Cosmetics Index spotlights leading UK‑based practitioners renowned for clinical expertise, safety and natural‑looking outcomes. The list includes dermatologists, pharmacists and aesthetic doctors offering injectables, laser therapies, scalp treatments and hormone‑based solutions for high‑net‑worth (HNW) clients worldwide. Industry...
PreVenTB Trial: Considerations for Interpreting Extrapulmonary Tuberculosis Efficacy and Tuberculin Skin Test-Stratified Analyses
The PreVenTB phase‑3 trial evaluated the recombinant BCG vaccine VPM1002 and the subunit vaccine Immuvac in 12,700 Indian household contacts, but neither met the primary endpoint of preventing microbiologically confirmed tuberculosis. The authors noted a 23.1% versus 20.3% six‑month tuberculin...
Hospice Staff to Call for £112m Funding Boost in Westminster Protest
Hospice staff across England are delivering a letter to the Prime Minister demanding a £112.5 million (≈$140 million) boost in recurring funding. Nearly 60% of hospices have already cut or plan to cut frontline services, leaving 380 beds idle and community visits...
Drug-Resistant Fungi Prompt a Five-Step Global Plan Ahead of WHO's 2026 Update
An international consortium of 50 researchers led by Radboudumc has issued a five‑step plan to curb the rise of drug‑resistant fungi. The strategy—covering awareness, surveillance, infection control, optimized drug use, and investment—aims to shape the World Health Organization’s 2026 Global...
Off the Shelf Cell Therapies for Bone Marrow Transplantation with Ossium Health’s Kevin Caldwell — Episode 251
In episode 251 of the Xtalks Life Science Podcast, Kevin Caldwell, CEO and co‑founder of Ossium Health, discusses the company’s pioneering off‑the‑shelf bone‑marrow therapy derived from deceased organ donors. The treatment aims to solve long‑standing clinical and logistical hurdles in...
Northamptonshire ICB Ranked England’s Most Digitally Mature
Northamptonshire Integrated Care Board has been ranked as England’s most digitally mature integrated care system, a dramatic rise from its low‑performing status just two years ago. The new Northamptonshire Care Record now aggregates health and social data for over 800,000...
Poll Reveals Millions of Americans Consult AI Before, After—And Sometimes Instead Of—Seeing a Doctor
A Gallup‑West Health poll of 5,660 U.S. adults finds that over 66 million Americans—one in four—have used AI tools or chatbots for health information in the past month. Most users (57%) turn to AI to supplement care, seeking quick answers or...
Viewpoint: CRISPR and mRNA — Under Attack by Technology Skeptics — Poised to Save Millions of Children with Rare Diseases
Rare genetic diseases affect roughly 25 million Americans and generate about $400 billion in annual medical costs, yet fewer than five percent have FDA‑approved therapies. The scarcity of treatments stems from the economics of drug development for tiny patient pools. Recent breakthroughs...
Idiopathic Hypersomnia and Narcolepsy: What’s the Difference?
Idiopathic hypersomnia (IH) and narcolepsy are distinct neurological sleep disorders that both cause excessive daytime sleepiness, but they differ in symptom patterns, underlying biology, and treatment options. IH is characterized by prolonged, unrefreshing sleep, severe sleep inertia, and cognitive fog...
Nearly 200 Radiology Reports Never Sent to Patients' Referring Providers, Health Authority Says
A regional health authority in New Zealand’s Northland region discovered that 180 radiology reports were never transmitted to referring providers, primarily due to an IT glitch affecting reports from June 2025 and earlier. Health NZ officials launched an investigation after patient complaints,...
Magnesium Effects in Critically Ill Patients
Magnesium deficiency is a pervasive problem in intensive care, affecting up to 65% of ICU patients even when serum tests appear normal. Low intracellular magnesium is linked to higher rates of sepsis, prolonged mechanical ventilation, and increased mortality. Clinical studies...
100+ Signatures in Six Hours for Cover All Coloradans
In 6 hours there are over 100 signatures supporting Cover All Coloradans I’m so grateful to you all for taking the time to show your support for this critical program 🫶🏾
Fatty Liver Affects 1.3B Now, 2B by 2050
1.3 Billion Globally Have Fatty Liver Disease; Numbers To Reach 2 Billion By 2050: Lancet Study https://t.co/DqKS8L0hCx #research #fattyliver #disease #health
Not About Food: The Brutal Truth About Malnutrition
Indonesia faces a chronic stunting crisis affecting millions of children, but the problem is less about food scarcity and more about a broken trust chain between mothers and the untrained community health workers, known as kader. Over 68 million mothers rely...
Re: Effect of a Clinical Decision Support System on Stroke Care Quality and Outcomes in Patients with Acute Ischaemic Stroke...
A cluster‑randomised trial (GOLDEN BRIDGE II) evaluated an AI‑driven clinical decision support system (CDSS) for acute ischemic stroke. The intervention lowered three‑month vascular events from 3.9% to 2.9% (adjusted HR 0.74) and improved several composite performance measures. However, the study found no significant...
Waist-to-Height Ratio Outperforms BMI in Predicting Hypertension Risk
A new study by the University of Eastern Finland and Rutgers University shows that waist‑to‑height ratio (WHtR) cut‑offs predict elevated blood pressure and hypertension more accurately than body mass index (BMI). Analyzing 19,124 U.S. participants from NHANES 2015‑2023, researchers found...
Study Identifies New Genes Linked to Severe Pregnancy Sickness
USC researchers expanded the genetic landscape of hyperemesis gravidarum, identifying nine additional genes alongside the previously known GDF15, GFRAL, IGFBP7, and PGR. The genome‑wide association study analyzed 10,974 HG cases and 461,461 controls across diverse ancestries, the largest cohort to...
FDA Requests Additional Safety Data on Eli Lilly's Newly Approved Obesity Pill Foundayo
The U.S. Food and Drug Administration has formally asked Eli Lilly to provide further safety information on its recently cleared oral GLP‑1 obesity medication Foundayo. The regulator’s letter, signed on April 1, flags liver‑injury signals and mandates post‑marketing studies on cardiovascular events,...
Eli Lilly’s Jaypirca Secures Fourth Phase III Win in CLL, Paving Way for Label Expansion
Eli Lilly announced that its BTK inhibitor pirtobrutinib (Jaypirca) achieved its fourth Phase III success in chronic lymphocytic leukemia, meeting the primary endpoint of improved progression‑free survival. The result clears a path for a U.S. label expansion and underpins a GlobalData...
FDA Launches READI-Home Innovation Challenge: Opportunities—And Tensions—For Home-Use Device Developers
On April 7, 2026 the FDA’s Center for Devices and Radiological Health launched the READI‑Home Innovation Challenge, a two‑phase program aimed at accelerating home‑use medical devices that can cut hospital readmissions. Developers submit a 16‑page Q‑Submission by September 30, after which up...
Labcorp, AWS and Datavant Launch AI‑Powered Platform to Speed Alzheimer’s Research
Labcorp announced a partnership with Amazon Web Services and Datavant to roll out an AI‑driven real‑world data platform for Alzheimer’s research. The platform promises to compress data‑preparation cycles from months to minutes, leveraging Labcorp’s diagnostic data and privacy‑preserving tokenization. The...
Behavioral Design Project Aims to Reduce Benzodiazepine Overuse
A collaborative project between the Universitat Oberta de Catalunya (UOC) and Badalona Serveis Assistencials (BSA) is launching a behavioural‑design pilot to curb long‑term benzodiazepine use in primary‑care. The three‑month intervention, beginning in April at the CAP Martí i Julià centre,...
Inflammation & Immune System - A Deep Dive Into Genetic Pathways for Actionable Insights
A detailed genetic analysis of inflammation and immune pathways identified three high‑impact homozygous variants: PTPN22 R620W, CFH Y402H, and NFE2L2 –617. The report translates these findings into concrete clinical actions, including autoimmune and thyroid screening, baseline retinal imaging for age‑related...
Eka Ventures Raises $107 Million for Second Impact Fund, Becomes UK’s Largest Early‑Stage ESG VC
Eka Ventures announced the final close of its second fund at $107 million (£80 million), taking total assets under management to $200 million. The fund will back up to 30 pre‑seed and seed‑stage UK startups in health, wellbeing and sustainability, underscoring growing investor...
HHS Ignores Proven Environmental Triggers for Autism
Here’s my statement from @BakerInstitute @RiceUniversity @RiceUNews on why this was always a nonstarter, meanwhile HHS refuses to investigate the few actual know environmental exposures that do interact with autism genes https://t.co/pxLaDLInlf
FDA Introduces Standardized Framework for Gene Therapy Safety
New FDA guidance on evaluating the safety of gene therapies will establish a more predictable development process as these measures are implemented They provide a standardized, layered framework for uncovering off-target effects and other safety issues https://t.co/D7lsBeZybT
MedPAC: No ‘Statistically Significant’ Impact From Medicare Advantage Growth On Home Health Margins
MedPAC reported that the growth of Medicare Advantage (MA) has not produced a statistically significant impact on home‑health provider margins, despite industry concerns. A 10% increase in MA penetration was linked to a modest 2.7% decline in all‑payer revenue for...
Exposing Antivaccine Rhetoric Masquerading as Real Science
1/n Here’s a thread on why this is nonsense. I think it’s important to debunk bc increasingly the antivaccine activists and their rhetoric are trying to sound more like real science even though it’s fake.
Study Finds Long COVID Leaves a Distinct Immune Signature in the Blood
A collaborative Australian‑Norwegian study identified a distinct set of inflammatory and neurological proteins in the blood of long COVID patients, measured six to nine months after infection. Machine‑learning analysis highlighted IL‑20, MCP‑1 and NBL1 as key discriminators from recovered and...
Experiences with Ezetimibe or Empagliflozin?
A Reddit longevity thread shows users taking ezetimibe (10 mg) and empagliflozin (10‑25 mg) report minimal side effects while noting modest metabolic benefits. Empagliflozin is praised for flattening post‑prandial glucose spikes but can increase urination; ezetimibe is credited with lowering LDL‑C to...
Whistleblower Sparks Investigation Into Health New Zealand’s Medical Scanning Services
A protected disclosure by consultant radiologist Dr. Bryan Wolf has triggered an independent inquiry into Health New Zealand’s radiology services, led by former Solicitor‑General Michael Heron KC. The board confirmed the investigation after earlier reports revealed patient harm from outdated...
MicroRNA Signature Predicts Localized Clear Cell RCC
A new commentary in the British Journal of Cancer re‑examines the Bio‑miR study, which proposed a microRNA signature to predict outcomes in localized clear cell renal cell carcinoma (ccRCC). The authors highlight statistical and reproducibility concerns, showing that several miRNA...
Egypt Launches State‑Faith Initiative to Deliver Free Household Mental‑Health Support
Egypt's Ministry of Youth and Sports announced a joint program with the Health Ministry, Al‑Azhar and the Orthodox Church to offer free, confidential psychological counseling to every Egyptian household. The initiative seeks to address soaring anxiety and depression rates by...
Common Osteoporosis Drugs Could Slow or Halt Aneurysm Progression
Researchers at Nagoya University discovered that clonal hematopoiesis, found in about 60% of aortic aneurysm patients, accelerates aneurysm expansion. In mouse models, Tet2‑mutant macrophages promoted elastin loss and matrix degradation via the RANK/RANKL pathway. Treatment with FDA‑approved osteoporosis drugs—anti‑RANKL antibodies...
A Bittersweet 20th Birthday for Romneycare
Mitt Romney marked the 20th anniversary of Massachusetts’ 2006 health‑care reform, known as Chapter 58 or “Romneycare,” highlighting its dramatic impact on coverage and its bipartisan origins. The law cut the state’s non‑elderly uninsured rate from 13.4% to 5.8% in the...
Turkish PDQoL-7 Validated for Older Adults
Turkish researchers have validated a version of the Parkinson’s Disease Quality of Life‑7 (PDQoL‑7) scale specifically for older adults, publishing the findings in BMC Geriatrics. The validation demonstrated strong reliability, internal consistency, and construct and criterion validity using factor analysis...
FDA Sends Letters to 2,200 Sponsors, Demanding Public Trial Results
The U.S. Food and Drug Administration has formally notified more than 2,200 drug developers that they must post pending clinical trial results on ClinicalTrials.gov, highlighting that nearly 30% of mandated studies remain unpublished. The agency warns of civil penalties and...
Botanic Healthcare Appoints Kamalakar V. Arcot as Group CEO to Drive Global Expansion
Botanic Healthcare announced the appointment of Kamalakar V. Arcot as Group Chief Executive Officer. The veteran executive brings more than 20 years of pharma and life‑science experience to steer the company’s global‑first strategy, strengthen supply‑chain execution and accelerate market expansion.
AWS Unveils Amazon Bio Discovery, Cutting Drug Design Time From Months to Weeks
Amazon Web Services launched Amazon Bio Discovery, an AI‑driven platform that lets researchers design and evaluate drug molecules without writing code. Early adopters such as Bayer, the Broad Institute and Memorial Sloan Kettering report that the tool can compress months‑long...